CHF Solutions Competitors, Revenue and Alternatives
Estimated Revenue & Financials
- CHF Solutions's estimated annual revenue is currently $5M per year.
- CHF Solutions received $5.4M in venture funding in July 2018.
- CHF Solutions's estimated revenue per employee is $75,758
- CHF Solutions has 66 Employees.
- CHF Solutions grew their employee count by -1% last year.
- CHF Solutions currently has 1 job openings.
|Competitor Name||Revenue||Number of Employees||Employee Growth||Total Funding|
|C-Axis and C-Ax...||$17.8M||71||1%||N/A|
What Is CHF Solutions?
CHF Solutions, Inc. (NASDAQ:CHFS) is a medical device company focused on commercializing the Aquadex FlexFlow system for Aquapheresis® therapy. The Aquadex FlexFlow system is indicated for temporary (up to eight hours) ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy, and extended (longer than 8 hours) ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization. All treatments must be administered by a healthcare provider, under physician prescription, both of whom having received training in extracorporeal therapies. The company's mission is to predict, measure, and control patient fluid balance through science, collaboration, and innovative medical technology. CHF Solutions is a Delaware corporation headquartered in Minneapolis, Minnesota with wholly owned subsidiaries in Australia and Ireland. The company has been listed on the NASDAQ Capital Market since February 2012.keywords:Healthcare,Healthcare Providers,Pharmaceuticals
Number of Employees
Employee Growth %
|Audrey Singh||Sr Director of Clinical Research||Email Available|
|Brad Currier||Director Of Operations||Email Available|
|John Erb||Chairman and CEO/President||Email Available|
|Teresa Buechler||Accounting Manager||Email Available|
|Harris Lewis||Therpay Development Manager||Email Available|
|Smullen Andrew||Regional Sales Manager||Email Available|
|Claudia Drayton||CFO||Email Available|
|Joe Cicero||Therapy Development Manager||Email Available|
|Rich Catalano||Senior Account Manager|
|Bruce Trittin||Director Strategic Accounts||Email Available|
CHF Solutions News
EDEN PRAIRIE, Minn., Sept. 06, 2019 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ:CHFS), today announced that, on September 3, ...
CHF Solutions, Inc. Appoints World-Renowned Heart Failure Cardiologist, Maria Rosa Costanzo, M.D. to Company's Board of Directors ...
Vaso (OTCMKTS:VASO) and CHF Solutions (NASDAQ:CHFS) are both small-cap medical companies, but which is the superior investment?
CHF Solutions Funding
|2011-07-26||$4.6M||Undisclosed||Summer Street Research Partner||Article|
|2011-09-22||$7.4M||Undisclosed||Street Research Partners||Article|
|2015-02-20||$10.0M||Undisclosed||Silicon Valley Bank||Article|
|2017-04-26||$9.2M||Undisclosed||Ladenburg Thalmann & Co||Article|
|2018-07-05||$5.4M||Undisclosed||Ladenburg Thalmann & Co||Article|
CHF Solutions Executive Hires
|2014-05-07||Kimberly Oleson||SVP Clinical Affairs||Article|
|2014-06-17||Brian Brown||SVP Operations/Technology||Article|
|2016-01-06||Eric Lovett||VP Clinical Affairs||Article|
|2016-08-17||Megan Brandt||VP Regulatory Affairs/Quality Assurance||Article|